BridgeBio Pharma (BBIO) Minority Interest (2018 - 2026)
BridgeBio Pharma (BBIO) recorded Minority Interest of $10.34 million in Q2 2026, up 4.6% from $9.89 million a year earlier but down 0.9% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Minority Interest (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma reported Minority Interest of $10.6 million, up 4.4% from FY2024.
- Annual Minority Interest has a five-year compound annual growth rate of -26.2% (FY2020 to FY2025).
- Across earlier years, Minority Interest came in at $10.15 million in FY2024 (-9.7%), $11.24 million in FY2023 (-0.3%), $11.28 million in FY2022 (+230.7%) and $3.41 million in FY2021 (-92.9%).
- Quarterly Minority Interest has ranged from $336,000 in Q1 2022 to $12.41 million in Q3 2023 over the past five years.
- On a year-over-year basis, Minority Interest has increased for three consecutive quarters, with an average decline of 5.2% over the last eight quarters.
- Peak year-over-year performance for Minority Interest in the last five years was growth of 230.7% in Q4 2022, against a decline of 94.3% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.44 million (Q1 2026), $10.6 million (Q4 2025) and $10.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.34 Bn | 1,100.93 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.91 Bn | 534.44 Bn | 17.26 Bn |
| 3 | AbbVie | 505.47 Bn | 478.59 Bn | 12.70 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.18 Bn | 262.17 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 236.22 Bn | 191.62 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn |
| 9 | Pfizer | 170.14 Bn | 116.79 Bn | 10.94 Bn |
| 10 | BridgeBio Pharma | 13.38 Bn | 10.48 Bn | 228.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.34 Mn |
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | 10.15 Mn |
| Sep 30, 2024 | 10.89 Mn |
| Jun 30, 2024 | 11.06 Mn |
| Mar 31, 2024 | 12.15 Mn |
| Dec 31, 2023 | 11.24 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.05 Mn |
| Mar 31, 2023 | 12.26 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 336,000.00 |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 4.56 Mn |
API Access
BridgeBio Pharma Minority Interest API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=minority-interest&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "minority-interest", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=minority-interest&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();